Mark  Kaye net worth and biography

Mark Kaye Biography and Net Worth

Mark Kaye is the Chief Financial Officer and Executive Vice President of Elevance Health, leading the company's finance organization in addition to oversight of Carelon. He plays a crucial role in both transforming a traditional health benefits organization and in shaping the company’s growth strategies in the dynamic managed healthcare landscape. Kaye previously served as the Chief Financial Officer of Moody’s Corporation and Chief Financial Officer of Massachusetts Mutual Life Insurance Company.

What is Mark Kaye's net worth?

The estimated net worth of Mark Kaye is at least $8.59 million as of October 22nd, 2026. Kaye owns 19,919 shares of Elevance Health stock worth more than $8,587,280 as of October 26th. This net worth evaluation does not reflect any other investments that Kaye may own. Learn More about Mark Kaye's net worth.

How do I contact Mark Kaye?

The corporate mailing address for Kaye and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Mark Kaye's contact information.

Has Mark Kaye been buying or selling shares of Elevance Health?

During the last quarter, Mark Kaye has sold $4,658,335.92 of Elevance Health stock. Most recently, Mark Kaye sold 10,584 shares of the business's stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $440.13, for a transaction totalling $4,658,335.92. Following the completion of the sale, the chief financial officer now directly owns 19,919 shares of the company's stock, valued at $8,766,949.47. Learn More on Mark Kaye's trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (President, CEO & Director), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Mark Kaye (CFO), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, insiders at the sold shares 3 times. They sold a total of 10,761 shares worth more than $4,726,478.19. The most recent insider tranaction occured on October, 22nd when CFO Mark Kaye sold 10,584 shares worth more than $4,658,335.92. Insiders at Elevance Health own 0.3% of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 10/22/2026.

Mark Kaye Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/22/2026Sell10,584$440.13$4,658,335.9219,919View SEC Filing Icon  
4/24/2025Sell4,588$424.82$1,949,074.1618,977View SEC Filing Icon  
See Full Table

Mark Kaye Buying and Selling Activity at Elevance Health

This chart shows Mark Kaye's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $431.49
Low: $430.15
High: $442.25

50 Day Range

MA: $408.32
Low: $381.68
High: $445.85

2 Week Range

Now: $431.49
Low: $274.84
High: $450.69

Volume

463,464 shs

Average Volume

1,597,523 shs

Market Capitalization

$93.23 billion

P/E Ratio

18.41

Dividend Yield

1.56%

Beta

0.7